Drug prices are mysterious and unpredictable for many consumers With the average person’s out-of-pocket expense for a drug determined by several interdependent factors, planning for care is harder, and trying…
The post Deconstructing Drug Pricing Strat…

Biologic drugs are far more complex than traditional “small molecule” drugs Generic drugs as we know them differ from biosimilars, which are designed to be less costly alternatives to branded biologic drugs.…
The post Exploring Biosimilars as a Drug Pa…

Drug repositioning offers an alternative path to drug development Researchers at the US drug group Pfizer’s Sandwich research center while working on an angina treatment found a compound by the…
The post Using clinical trial information to forecast fut…

The time and expense involved with introducing a new drug can be phenomenal Whether the “blockbuster drug” era is over, as some claim, or not, coming up with brand new…
The post Leveraging Patent Pending Data for Pharmaceuticals appeared first on DrugP…

Data from clinical trials can improve pharmaceutical forecasting Pharmaceutical investing requires a level of attention to detail that is not as critical in less complex or less regulated industries. The…
The post How Clinical Trial Data Supports Accur…

Pharmaceutical manufacturing can benefit from expired or abandoned patents Abandoned and expired patents can have outstanding potential for pharmaceutical manufacturing. Patents confer a set of exclusive rights for a defined…
The post Abandoned and Exp…

Submitting an abbreviated new drug application to the Food and Drug Administration Generic Drugs are Critical for Cost Savings The US Food and Drug Administration (FDA) approved over 700 generic…
The post Obtaining Generic Drug Approval in the United S…

Preparation for drug patent expiration isn’t a one-size-fits-all process Drug patents allow pharmaceutical companies, having invested heavily in new products, to enjoy a defined period of exclusivity before competitors enter…
The post Top Strategies fo…